{"hands_on_practices": [{"introduction": "To truly grasp enzyme kinetics, we begin with the fundamental relationship between substrate concentration and reaction velocity. This practice explores the concept of enzyme saturation, a cornerstone of the Michaelis-Menten model, within a neurobiological context. By working through this hypothetical scenario [@problem_id:2335614], you will quantitatively see why simply increasing the amount of a precursor does not proportionally increase the rate of product synthesis, a critical principle in understanding metabolic flux and the efficacy of therapeutic interventions.", "problem": "In a specific population of dopaminergic neurons, the synthesis of dopamine from its precursor, L-DOPA, is catalyzed by the enzyme Aromatic L-amino acid decarboxylase (AADC), also known as DOPA decarboxylase. The kinetic behavior of this enzyme with respect to L-DOPA can be described by the Michaelis-Menten model. For AADC in these neurons, the Michaelis constant ($K_M$) for L-DOPA is $1.5 \\times 10^{-4}$ M, and the enzyme exhibits a maximum reaction velocity of $V_{max}$.\n\nSuppose that under a certain physiological condition, the steady-state concentration of L-DOPA available to the enzyme in the presynaptic terminal is $6.0 \\times 10^{-4}$ M. A new therapeutic intervention then successfully doubles this intracellular concentration of L-DOPA.\n\nCalculate the ratio of the new rate of dopamine synthesis to the original rate. Express your answer as a decimal rounded to three significant figures.", "solution": "The Michaelis-Menten rate equation for substrate concentration $S$ is\n$$\nv=\\frac{V_{max} S}{K_{M}+S}.\n$$\nLet the original substrate concentration be $S_{1}=6.0 \\times 10^{-4}$ and the new concentration be $S_{2}=2S_{1}=1.2 \\times 10^{-3}$, with $K_{M}=1.5 \\times 10^{-4}$. Note that\n$$\n\\frac{S_{1}}{K_{M}}=\\frac{6.0 \\times 10^{-4}}{1.5 \\times 10^{-4}}=4 \\quad \\Rightarrow \\quad S_{1}=4K_{M},\n$$\nand\n$$\nS_{2}=2S_{1}=8K_{M}.\n$$\nThus,\n$$\nv_{1}=\\frac{V_{max} \\cdot 4K_{M}}{K_{M}+4K_{M}}=V_{max}\\cdot \\frac{4}{5}, \\qquad\nv_{2}=\\frac{V_{max} \\cdot 8K_{M}}{K_{M}+8K_{M}}=V_{max}\\cdot \\frac{8}{9}.\n$$\nThe desired ratio is\n$$\n\\frac{v_{2}}{v_{1}}=\\frac{\\frac{8}{9}}{\\frac{4}{5}}=\\frac{8}{9}\\cdot \\frac{5}{4}=\\frac{10}{9}\\approx 1.11 \\text{ (to three significant figures)}.\n$$", "answer": "$$\\boxed{1.11}$$", "id": "2335614"}, {"introduction": "Enzyme activity is rarely unregulated in a biological system; it is finely tuned by activators and inhibitors. This exercise [@problem_id:1704525] moves from basic kinetics to the crucial topic of regulation, focusing on competitive inhibition—a common mechanism for many pharmaceutical drugs. You will use the Michaelis-Menten equation as a tool to predict how an inhibitor alters the substrate concentration required to achieve a target reaction rate, a core skill in neuropharmacology for understanding drug-enzyme interactions.", "problem": "A research team is studying a novel enzyme, \"Fructokinase-P\" (FKP), isolated from a genetically modified sugarcane variety designed for enhanced sucrose production. The enzyme catalyzes the phosphorylation of fructose, a key step in sugar metabolism. In the absence of any inhibitors, FKP exhibits a Michaelis constant of $K_M$ and a maximum reaction velocity of $V_{max}$.\n\nThe team then investigates the effect of a newly developed herbicide, \"GlycoBlock,\" on the activity of FKP. They determine that GlycoBlock acts as a competitive inhibitor of the enzyme. When the herbicide is present at a concentration $[I]$, its binding to the enzyme is characterized by an inhibition constant $K_i$.\n\nUnder these inhibitory conditions (with GlycoBlock present at concentration $[I]$), what concentration of the substrate, fructose, is required for the enzyme to achieve a reaction velocity equal to one-third of its original, uninhibited maximum velocity, $V_{max}$? Express your answer as a symbolic expression in terms of $K_M$, $K_i$, and $[I]$.", "solution": "For Michaelis-Menten kinetics without inhibitor, the rate is given by\n$$\nv=\\frac{V_{max}[S]}{K_{M}+[S]}.\n$$\nFor competitive inhibition at inhibitor concentration $[I]$ with inhibition constant $K_{i}$, the effect is to increase the apparent Michaelis constant by a factor $\\alpha$ while leaving $V_{max}$ unchanged, where\n$$\n\\alpha=1+\\frac{[I]}{K_{i}},\n$$\nso the rate becomes\n$$\nv=\\frac{V_{max}[S]}{\\alpha K_{M}+[S]}.\n$$\nWe require the substrate concentration $[S]$ such that the inhibited rate equals one-third of the original (uninhibited) maximum velocity, that is\n$$\nv=\\frac{1}{3}V_{max}.\n$$\nSet and solve:\n$$\n\\frac{V_{max}[S]}{\\alpha K_{M}+[S]}=\\frac{1}{3}V_{max}.\n$$\nCancel $V_{max}$ on both sides to obtain\n$$\n\\frac{[S]}{\\alpha K_{M}+[S]}=\\frac{1}{3}.\n$$\nCross-multiplying gives\n$$\n3[S]=\\alpha K_{M}+[S],\n$$\nhence\n$$\n2[S]=\\alpha K_{M}\\quad\\Rightarrow\\quad [S]=\\frac{\\alpha K_{M}}{2}.\n$$\nSubstituting $\\alpha=1+\\frac{[I]}{K_{i}}$ yields\n$$\n[S]=\\frac{K_{M}}{2}\\left(1+\\frac{[I]}{K_{i}}\\right).\n$$", "answer": "$$\\boxed{\\frac{K_{M}}{2}\\left(1+\\frac{[I]}{K_{i}}\\right)}$$", "id": "1704525"}, {"introduction": "After understanding the mathematical models of inhibition, it is essential to learn how these mechanisms are identified from experimental data. This problem [@problem_id:2335559] introduces the Lineweaver-Burk plot, a classic method for visualizing kinetic data and diagnosing inhibitor types. By interpreting the distinct graphical patterns produced by different inhibitors, you will develop the practical skill of translating raw experimental observations into a mechanistic understanding of enzyme regulation.", "problem": "A neuropharmacologist is investigating a novel enzyme, \"Synaptase,\" which is crucial for recycling a specific CNS neurotransmitter. The kinetics of this enzyme are studied using the Michaelis-Menten model. To characterize potential drug candidates, two inhibitory compounds, Compound A and Compound B, are tested. The researcher collects data on the initial reaction velocity ($v_0$) at various substrate concentrations ($[S]$) under three conditions: (1) with the enzyme alone, (2) in the presence of a fixed concentration of Compound A, and (3) in the presence of a fixed concentration of Compound B.\n\nWhen the reciprocal of the initial velocity ($1/v_0$) is plotted against the reciprocal of the substrate concentration ($1/[S]$) for all three conditions, a Lineweaver-Burk plot is generated. The analysis reveals the following observations:\n\n1. The line corresponding to the condition with Compound A has a different slope than the uninhibited enzyme line, and the two lines intersect at a single point on the positive y-axis.\n2. The line corresponding to the condition with Compound B also has a different slope than the uninhibited enzyme line, and these two lines intersect at a single point on the negative x-axis.\n\nBased on these observations, identify the modes of inhibition for Compound A and Compound B.\n\nA. Compound A is a non-competitive inhibitor; Compound B is a competitive inhibitor.\n\nB. Compound A is a competitive inhibitor; Compound B is a non-competitive inhibitor.\n\nC. Both Compound A and Compound B are competitive inhibitors.\n\nD. Both Compound A and Compound B are non-competitive inhibitors.\n\nE. Compound A is an uncompetitive inhibitor; Compound B is a competitive inhibitor.\n\nF. Compound A is a competitive inhibitor; Compound B is an uncompetitive inhibitor.", "solution": "We start with Michaelis–Menten kinetics for initial velocity $v$ as a function of substrate concentration $[S]$:\n$$\nv=\\frac{V_{\\max}[S]}{K_{M}+[S]}.\n$$\nTaking the reciprocal gives the Lineweaver–Burk form:\n$$\n\\frac{1}{v}=\\frac{K_{M}}{V_{\\max}}\\cdot\\frac{1}{[S]}+\\frac{1}{V_{\\max}}.\n$$\nFrom this linear equation, the slope is $K_{M}/V_{\\max}$, the $y$-intercept is $1/V_{\\max}$, and the $x$-intercept is $-1/K_{M}$.\n\nFor a competitive inhibitor with inhibitor concentration $[I]$ and inhibition constant $K_{i}$, define $\\alpha=1+[I]/K_{i}$. The rate law becomes\n$$\nv=\\frac{V_{\\max}[S]}{\\alpha K_{M}+[S]},\n$$\nso the Lineweaver–Burk equation is\n$$\n\\frac{1}{v}=\\frac{\\alpha K_{M}}{V_{\\max}}\\cdot\\frac{1}{[S]}+\\frac{1}{V_{\\max}}.\n$$\nThus, the $y$-intercept $1/V_{\\max}$ is unchanged while the slope increases to $(\\alpha K_{M})/V_{\\max}$. Therefore, the inhibited and uninhibited lines intersect on the positive $y$-axis (same $y$-intercept, different slopes). This matches observation 1, so Compound A is a competitive inhibitor.\n\nFor a pure noncompetitive inhibitor with parameter $\\alpha'=1+[I]/K_{i}'$, the effect is to reduce $V_{\\max}$ to $V_{\\max}/\\alpha'$ without changing $K_{M}$. The rate law can be written as\n$$\nv=\\frac{(V_{\\max}/\\alpha')[S]}{K_{M}+[S]},\n$$\nand the Lineweaver–Burk equation is\n$$\n\\frac{1}{v}=\\frac{\\alpha' K_{M}}{V_{\\max}}\\cdot\\frac{1}{[S]}+\\frac{\\alpha'}{V_{\\max}}.\n$$\nHere, the $x$-intercept $-1/K_{M}$ is unchanged while both the slope and $y$-intercept increase in proportion to $\\alpha'$. Consequently, the inhibited and uninhibited lines intersect on the negative $x$-axis (same $x$-intercept, different slopes). This matches observation 2, so Compound B is a noncompetitive inhibitor.\n\nUncompetitive inhibition would yield parallel lines (as the slope $K_{M}/V_{max}$ is unchanged) with both intercepts shifted, which is not observed here.\n\nTherefore, Compound A is competitive and Compound B is noncompetitive, corresponding to option B.", "answer": "$$\\boxed{B}$$", "id": "2335559"}]}